PuraPharm Corporation Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was HKD 195.08 million compared to HKD 230.76 million a year ago. Net loss was HKD 37.68 million compared to HKD 39.9 million a year ago.

Basic loss per share from continuing operations was HKD 0.0954 compared to HKD 0.1012 a year ago.